{"date":"2026-02-10","count":14,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6657-2026-02-10-2142-1ry1ejg","company_id":"6657","company":"華安","market":"上市","industry":"生技醫療","date":"2026-02-10","time":"21:42:11","subject":"本公司接獲衛生福利部函文通知，本公司研發中新藥ENERGI-F703EB遺傳性表皮分解性水皰症乳膏臨床試驗計畫一案，衛生福利部同意試驗進行執行人體二期臨床試驗(IND)。","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：華安（6657），2026-02-10 21:42，「本公司接獲衛生福利部函文通知，本公司研發中新藥ENERGI-F703EB遺傳性表皮分解性水皰症乳膏臨床試驗計畫一案，衛生」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4736-2026-02-10-1849-1fqkmsr","company_id":"4736","company":"泰博","market":"上市","industry":"生技醫療","date":"2026-02-10","time":"18:49:28","subject":"澄清媒體報導","clause":"第51款","fact_date":"2026-02-09","cite_as":"公開資訊觀測站重大訊息：泰博（4736），2026-02-10 18:49，「澄清媒體報導」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6817-2026-02-10-1737-5zukgk","company_id":"6817","company":"溫士頓","market":"興櫃","industry":"生技醫療","date":"2026-02-10","time":"17:37:04","subject":"公告本公司與Medic Vision AI Limited簽訂業務合作備忘錄","clause":"第8款","fact_date":"2026-02-10","cite_as":"公開資訊觀測站重大訊息：溫士頓（6817），2026-02-10 17:37，「公告本公司與Medic Vision AI Limited簽訂業務合作備忘錄」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3176-2026-02-10-1733-y4kc6i","company_id":"3176","company":"基亞","market":"上櫃","industry":"生技醫療","date":"2026-02-10","time":"17:33:28","subject":"代重要子公司Medic Vision AI Limited 公告簽訂新業務備忘錄","clause":"第10款","fact_date":"2026-02-10","cite_as":"公開資訊觀測站重大訊息：基亞（3176），2026-02-10 17:33，「代重要子公司Medic Vision AI Limited 公告簽訂新業務備忘錄」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7827-2026-02-10-1730-1twflfh","company_id":"7827","company":"漢康-KY創","market":"上市","industry":"生技醫療","date":"2026-02-10","time":"17:30:56","subject":"公告本公司第一屆永續發展委員會委員","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：漢康-KY創（7827），2026-02-10 17:30，「公告本公司第一屆永續發展委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7799-2026-02-10-1730-a1eshs","company_id":"7799","company":"禾榮科","market":"上市","industry":"生技醫療","date":"2026-02-10","time":"17:30:13","subject":"本公司研發之F18 FBPA注射劑向台灣衛生福利部食品藥物管理署(TFDA)提出學術研究用人體臨床試驗IND申請許可之申復審查通過","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：禾榮科（7799），2026-02-10 17:30，「本公司研發之F18 FBPA注射劑向台灣衛生福利部食品藥物管理署(TFDA)提出學術研究用人體臨床試驗IND申請許可之申」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7827-2026-02-10-1728-br4i01","company_id":"7827","company":"漢康-KY創","market":"上市","industry":"生技醫療","date":"2026-02-10","time":"17:28:07","subject":"公告本公司董事會決議115年股東常會相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：漢康-KY創（7827），2026-02-10 17:28，「公告本公司董事會決議115年股東常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6574-2026-02-10-1718-xsrhqv","company_id":"6574","company":"霈方","market":"上櫃","industry":"生技醫療","date":"2026-02-10","time":"17:18:00","subject":"補充說明本公司取得有價證券投資計畫","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：霈方（6574），2026-02-10 17:18，「補充說明本公司取得有價證券投資計畫」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6876-2026-02-10-1613-vqkii","company_id":"6876","company":"朗齊生醫*","market":"興櫃","industry":"生技醫療","date":"2026-02-10","time":"16:13:24","subject":"公告本公司註銷限制員工權利新股減資變更登記完成","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：朗齊生醫*（6876），2026-02-10 16:13，「公告本公司註銷限制員工權利新股減資變更登記完成」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-8279-2026-02-10-1604-1p2wp3n","company_id":"8279","company":"生展","market":"上櫃","industry":"生技醫療","date":"2026-02-10","time":"16:04:06","subject":"公告114年第4季財務報告董事會召開日期","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：生展（8279），2026-02-10 16:04，「公告114年第4季財務報告董事會召開日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4178-2026-02-10-1558-10w26le","company_id":"4178","company":"永笙-KY","market":"上市","industry":"生技醫療","date":"2026-02-10","time":"15:58:19","subject":"公告本公司董事會決議辦理初次上市前現金增資發行新股","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：永笙-KY（4178），2026-02-10 15:58，「公告本公司董事會決議辦理初次上市前現金增資發行新股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3184-2026-02-10-1538-18mrv67","company_id":"3184","company":"微邦","market":"興櫃","industry":"生技醫療","date":"2026-02-10","time":"15:38:38","subject":"公告本公司為全台第一家取得歐盟MDR醫材認證免持吸入噴霧器","clause":"第44款","fact_date":"2026-02-10","cite_as":"公開資訊觀測站重大訊息：微邦（3184），2026-02-10 15:38，「公告本公司為全台第一家取得歐盟MDR醫材認證免持吸入噴霧器」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4737-2026-02-10-1333-54swv6","company_id":"4737","company":"華廣","market":"上市","industry":"生技醫療","date":"2026-02-10","time":"13:33:40","subject":"公告本公司法人董事改派代表人","clause":"第6款","fact_date":"2026-02-10","cite_as":"公開資訊觀測站重大訊息：華廣（4737），2026-02-10 13:33，「公告本公司法人董事改派代表人」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6934-2026-02-10-1126-1tdnhwx","company_id":"6934","company":"心誠鎂","market":"上市","industry":"生技醫療","date":"2026-02-10","time":"11:26:47","subject":"本公司上市掛牌首五個營業日穩定價格操作結果","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：心誠鎂（6934），2026-02-10 11:26，「本公司上市掛牌首五個營業日穩定價格操作結果」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}